The sleeping aids market refers to the industry involved in the production and sale of products or medications designed to help individuals improve their sleep quality and address sleep-related issues. These aids can range from over-the-counter (OTC) sleep aids, such as herbal supplements and sleep-inducing teas, to prescription medications specifically formulated to treat sleep disorders.
The demand for sleeping aids has been steadily increasing due to various factors such as rising stress levels, lifestyle changes, and the prevalence of sleep disorders. Sleep-related problems, including insomnia, sleep apnea, restless legs syndrome, and narcolepsy, have become common concerns for individuals seeking better sleep and overall well-being.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7785
Segmentation of Density Meter Industry Research
- By Product :
- Sleep Apnea Devices
- Medication
- Mattresses & Pillows
- Sleep Laboratory Services
- By Sleep Disorder :
- Insomnia
- Sleep Apnea
- Restless Leg Syndrome
- Narcolepsy
- Sleepwalking
- Others
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Key Takeaways from Market Study
- The global sleeping aids market currently accounts for a valuation of US$ 83.1 billion.
- The market is projected to reach US$ 120 billion by the end of 2030.
- China’s market for sleeping aids is expected to reach a valuation of US$ 28.6 billion by 2030.
- Global sales of sleep apnea devices are predicted to increase at a CAGR of 6% during the forecast period.
Competitive Landscape
To increase their chances of growth, the top companies in the sleep aids market are focusing on acquisitions, new developments, and product launches. Manufacturers of sleeping aids are increasing product R&D spending as a key part of their business plan to meet the need of a certain patient population. Players in the market are also concentrating on expanding their geographic reach of both new and existing devices.
- The U.S. FDA approved a new medication application, orexin receptor antagonist DAYVIGOTM (lemborexant), which Eisai Co., Ltd. discovered and developed, in December 2019. Adults with insomnia defined by problems falling asleep, staying asleep, or maintaining sleep may use DAYVIGO.
Sleeping Aids Industry: Key Players
- Abecca Healthcare
- Becton, Dickinson and Company
- Betterlifehealthcare Ltd.
- Cadwell Industries, Inc.
- Compumedics Ltd.
- GlaxoSmithKline, Inc.
- Hill-Rom Holdings, Inc.
- Koninklijke Philips NV
- Lifeline Corporation Pte Ltd
- Merck & Co., Inc.
- Natus Medical, Inc.
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global sleeping aids market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2030.
The study divulges essential insights on the market on the basis of product (sleep apnea devices, medication, mattresses & pillows, sleep laboratory services) and sleep disorder (insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleepwalking, others), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).